Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EUROFORS: Teriparatide Sequential Therapy in Osteoporosis
NCT00191425Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Aug 2002
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of teriparatide in osteoporosis (4 arms), sponsored by Eli Lilly and Company. Primary endpoint: Lumbar Spine Bone Mineral Density at 24 months. Started Aug 2002; status: completed.
02
Drugs
teriparatide
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00191425.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00191425.